Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566

dc.contributor.authorNelson, Ryan S.
dc.contributor.authorSeligson, Nathan D.
dc.contributor.authorBottiglieri, Sal
dc.contributor.authorCarballido, Estrella
dc.contributor.authorDel Cueto, Alex
dc.contributor.authorImanirad, Iman
dc.contributor.authorLevine, Richard
dc.contributor.authorParker, Alexander S.
dc.contributor.authorSwain, Sandra M.
dc.contributor.authorTillman, Emma M.
dc.contributor.authorHicks, J. Kevin
dc.contributor.departmentPharmacology and Toxicology, School of Medicine
dc.date.accessioned2024-12-06T10:57:21Z
dc.date.available2024-12-06T10:57:21Z
dc.date.issued2024-10-25
dc.eprint.versionFinal published version
dc.identifier.citationNelson RS, Seligson ND, Bottiglieri S, et al. Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566. Cancers (Basel). 2024;16(21):3595. Published 2024 Oct 25. doi:10.3390/cancers16213595
dc.identifier.urihttps://hdl.handle.net/1805/44790
dc.language.isoen_US
dc.publisherMDPI
dc.relation.isversionof10.3390/cancers16213595
dc.relation.journalCancers
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.sourcePMC
dc.subjectUGT1A1
dc.subjectPharmacogenetics
dc.subjectIrinotecan
dc.subjectPazopanib
dc.subjectNilotinib
dc.subjectBelinostat
dc.subjectCancer
dc.subjectGenotype
dc.subjectPrecision medicine
dc.subjectGilbert’s syndrome
dc.titleCorrection: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nelson2024Correction-CCBY.pdf
Size:
154.18 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: